Friday

25-04-2025 Vol 19

Corvus Pharma initiates Part 1/1b trial of CPI-818 for T-cell lymphomas in China

Corvus Pharma initiates Part 1/1b trial of CPI-818 for T-cell lymphomas in China

Avatar photo

Brian Kraut